HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women

被引：0
作者：
Mwiza Gideon Singini
Elvira Singh
Debbie Bradshaw
Wenlong Carl Chen
Melitah Motlhale
Abram Bunya Kamiza
Chantal Babb de Villiers
Mazvita Muchengeti
Christopher G. Mathew
Robert Newton
Noemi Bender
Tim Waterboer
Freddy Sitas
机构：
[1] National Cancer Registry,Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences
[2] National Health Laboratory Service,Burden of Disease Research Unit
[3] University of the Witwatersrand,Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences
[4] South African Medical Research Council,Division of Human Genetics, School of Pathology, Faculty of Health Sciences
[5] University of the Witwatersrand,Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine
[6] University of the Witwatersrand,South African DSI
[7] King’s College London,NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA)
[8] MRC/UVRI and LSHTM Uganda Research Unit,Division of Infections and Cancer Epidemiology
[9] University of York,Centre for Primary Health Care and Equity, School of Population Health
[10] Stellenbosch University,Menzies Centre of Health Policy, School of Public Health
[11] German Cancer Research Center (DKFZ),undefined
[12] University of New South Wales,undefined
[13] University of Sydney,undefined
来源：
Infectious Agents and Cancer | / 17卷
关键词：
Cervical cancer; Human papillomavirus; E6 and E7, L1 proteins; Seropositivity; South Africa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 190 条
[1]  
de Martel C(2020)Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis Lancet Glob Heal 8 e180-e190
[2]  
Georges D(2012)New technologies and procedures for cervical cancer screening Vaccine 30 F107-F116
[3]  
Bray F(1993)Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer Int J cancer 53 591-596
[4]  
Ferlay J(1998)Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer J Clin Microbiol 36 475-480
[5]  
Clifford GM(1989)Antibodies against the human papillomavirus type 16 early proteins in human sera: Correlation of anti-e7 reactivity with cervical cancer J Natl Cancer Inst 81 1698-1704
[6]  
Cuzick J(2000)Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia Int J Cancer 85 313-318
[7]  
Bergeron C(2009)Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National health and nutrition examination survey 2003–2004 J Infect Dis 200 1059-1067
[8]  
von Knebel DM(2014)Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer Int J Cancer 135 2453-2461
[9]  
Gravitt P(1993)Serologic response in human papillomavirus-associated invasive cervical cancer Int J Cancer 55 780-784
[10]  
Jeronimo J(2003)Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later Am J Obstet Gynecol 188 49-55
12345678910